Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antiemesis. Clinical Practice Guidelines in Oncology.

Literature DB >> 19460282

Antiemesis. Clinical Practice Guidelines in Oncology.

David S Ettinger, Debra K Armstrong, Sally Barbour, Michael J Berger, Philip J Bierman, Bob Bradbury, Georgianna Ellis, Steve Kirkegaard, Dwight D Kloth, Mark G Kris, Dean Lim, Michael Anne Markiewicz, Lida Nabati, Carli Nesheiwat, Hope S Rugo, Steven M Sorscher, Lisa Stucky-Marshal, Barbara Todaro, Susan Urba.

Abstract

Mesh：

Substances：

Year: 2009 PMID： 19460282 DOI： 10.6004/jnccn.2009.0039

Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Comparison of two dosing schedules of palonosetron for the prevention of nausea and vomiting due to interleukin-2-based biochemotherapy.

Authors: Rahat Noor; Agop Y Bedikian; Sandy Mahoney; Roland Bassett; Kevin Kim; Nicholas Papadopoulos; Wen-Jen Hwu; Patrick Hwu; Jade Homsi
Journal: Support Care Cancer Date: 2012-01-25 Impact factor: 3.603

2. The effect of cigarette smoking on cancer treatment-related side effects.

Authors: Luke J Peppone; Karen M Mustian; Gary R Morrow; Ann M Dozier; Deborah J Ossip; Michelle C Janelsins; Lisa K Sprod; Scott McIntosh
Journal: Oncologist Date: 2011-12-01

3. Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients' quality of life.

Authors: P Fernández-Ortega; M T Caloto; E Chirveches; R Marquilles; J San Francisco; A Quesada; C Suárez; I Zorrilla; J Gómez; P Zabaleta; G Nocea; A Llombart-Cussac
Journal: Support Care Cancer Date: 2012-03-31 Impact factor: 3.603

4. Comparative trial of two intravenous doses of granisetron (1 versus 3 mg) in the prevention of chemotherapy-induced acute emesis: a double-blind, randomized, non-inferiority trial.

Authors: Daiki Tsuji; Yong-Il Kim; Keisei Taku; Shigeru Nakagaki; Yoshito Ikematsu; Hiromi Tsubota; Masato Maeda; Naoya Hashimoto; Masayuki Kimura; Takashi Daimon
Journal: Support Care Cancer Date: 2011-05-18 Impact factor: 3.603

Antiemesis. Clinical Practice Guidelines in Oncology.

1. Comparison of two dosing schedules of palonosetron for the prevention of nausea and vomiting due to interleukin-2-based biochemotherapy.

2. The effect of cigarette smoking on cancer treatment-related side effects.

3. Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients' quality of life.

4. Comparative trial of two intravenous doses of granisetron (1 versus 3 mg) in the prevention of chemotherapy-induced acute emesis: a double-blind, randomized, non-inferiority trial.

Review 5. Reducing the toxicity of cancer therapy: recognizing needs, taking action.

6. Computerized detection and analysis of cancer chemotherapy-induced emesis in a small animal model, musk shrew.

7. Treatment of Nausea and Vomiting During Chemotherapy.

Review 8. Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation.

9. Impact of 5-HT3 receptor antagonists on chemotherapy-induced nausea and vomiting: a retrospective cohort study.